Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A comprehensive clinical review of Dayvigo (lemborexant) withdrawal and discontinuation syndrome, including trial data, FAERS reports, FDA labeling, and physician-reviewed guidance on tapering safely.
Read clinical reviewA clinical breakdown of lemborexant (Dayvigo) adverse events by severity grade and patient subgroup, drawing on key trial data, FDA labeling, and FAERS post-market reports.
Read clinical reviewA clinician-reviewed guide to delayed-onset side effects of Dayvigo (lemborexant), including next-day somnolence, sleep paralysis, complex sleep behaviors, and long-term safety data from key trials and FAERS.
Read clinical reviewA detailed breakdown of lemborexant (Dayvigo) adverse event rates from SUNRISE-1, SUNRISE-2, FAERS data, and post-market literature, reviewed by the HealthRX medical team.
Read clinical reviewA detailed clinical review of Dayvigo (lemborexant) side effects, including rare, serious, and potentially long-lasting adverse events drawn from key trials, FDA labeling, and post-market surveillance data.
Read clinical reviewA clinical deep-dive into the rare but serious adverse events linked to lemborexant (Dayvigo), including sleep paralysis, complex sleep behaviors, suicidal ideation, and CNS depression, with trial data, FDA label guidance, and post-market reports.
Read clinical review